Reagenics wins an Israel Innovation Authority grant

Reagenics Research Ltd. received an Israel Innovation Authority grant in July 2025 under its development-to-manufacturing route.

The award is recorded in the Authority’s official database of supported companies, which identifies Reagenics as an R&D-stage biotechnology business serving pharmaceutical and nutraceutical markets.

The grant marks a milestone in Reagenics’ development of plant-cell cultivation technology.